John Lowe

8.2k total citations · 1 hit paper
143 papers, 6.0k citations indexed

About

John Lowe is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, John Lowe has authored 143 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 51 papers in Cellular and Molecular Neuroscience and 18 papers in Pharmacology. Recurrent topics in John Lowe's work include Neuropeptides and Animal Physiology (30 papers), Receptor Mechanisms and Signaling (27 papers) and Chemical Synthesis and Analysis (13 papers). John Lowe is often cited by papers focused on Neuropeptides and Animal Physiology (30 papers), Receptor Mechanisms and Signaling (27 papers) and Chemical Synthesis and Analysis (13 papers). John Lowe collaborates with scholars based in United States, United Kingdom and Australia. John Lowe's co-authors include Billy R. Martin, R. Michael Snider, Mario D. Aceto, Joseph G. Lombardino, Susan E. Drozda, Sandra P. Welch, Kelly P. Longo, David M. Compton, Fredric J. Vinick and Heidi A. Woody and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John Lowe

135 papers receiving 5.6k citations

Hit Papers

A Potent Nonpeptide Antag... 1991 2026 2002 2014 1991 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Lowe 2.9k 2.1k 1.5k 699 646 143 6.0k
Louis S. Harris 2.8k 1.0× 1.7k 0.8× 1.9k 1.3× 1.0k 1.5× 387 0.6× 178 5.3k
Irving W. Wainer 1.7k 0.6× 4.9k 2.3× 2.8k 1.9× 542 0.8× 544 0.8× 360 13.0k
Michael Kassiou 2.1k 0.7× 3.5k 1.6× 1.3k 0.9× 1.2k 1.7× 1.7k 2.6× 309 10.3k
Vincent Setola 1.8k 0.6× 2.8k 1.3× 676 0.5× 290 0.4× 634 1.0× 81 5.1k
Gareth Williams 1.4k 0.5× 3.5k 1.6× 1.3k 0.9× 1.0k 1.5× 586 0.9× 272 10.0k
Walter Lovenberg 4.1k 1.4× 5.1k 2.4× 827 0.6× 2.1k 3.0× 351 0.5× 245 11.7k
J. Paul Fawcett 1.6k 0.6× 3.3k 1.5× 875 0.6× 562 0.8× 275 0.4× 200 7.7k
Jean C. Shih 4.4k 1.5× 4.3k 2.0× 1.0k 0.7× 985 1.4× 861 1.3× 191 11.5k
Robert MacGregor 2.8k 1.0× 1.9k 0.9× 609 0.4× 910 1.3× 403 0.6× 109 7.9k
Matthew D. Krasowski 2.4k 0.9× 2.8k 1.3× 498 0.3× 592 0.8× 204 0.3× 202 8.6k

Countries citing papers authored by John Lowe

Since Specialization
Citations

This map shows the geographic impact of John Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lowe more than expected).

Fields of papers citing papers by John Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lowe. The network helps show where John Lowe may publish in the future.

Co-authorship network of co-authors of John Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of John Lowe. A scholar is included among the top collaborators of John Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lowe. John Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arulkumaran, N., et al.. (2018). Videolaryngoscopy versus direct laryngoscopy for emergency orotracheal intubation outside the operating room: a systematic review and meta-analysis. British Journal of Anaesthesia. 120(4). 712–724. 103 indexed citations
4.
Yeung, Yik A., Xiumin Wu, Arthur E. Reyes, et al.. (2010). A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life. Cancer Research. 70(8). 3269–3277. 56 indexed citations
5.
Chatterjee, Susmita, Pia Steensland, Jeffrey A. Simms, et al.. (2010). Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats. Neuropsychopharmacology. 36(3). 603–615. 90 indexed citations
6.
Li, Shuang, Terri L. Gilbert, R. Westenbroek, et al.. (2007). The absence of endogenous β-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation. Neuroscience. 146(4). 1795–1807. 58 indexed citations
7.
Hoek, Kristen L., Pierre Antony, John Lowe, et al.. (2006). Transitional B Cell Fate Is Associated with Developmental Stage-Specific Regulation of Diacylglycerol and Calcium Signaling upon B Cell Receptor Engagement. The Journal of Immunology. 177(8). 5405–5413. 33 indexed citations
8.
Lombardino, Joseph G. & John Lowe. (2004). The role of the medicinal chemist in drug discovery — then and now. Nature Reviews Drug Discovery. 3(10). 853–862. 249 indexed citations
9.
Lowe, John, Susan E. Drozda, Katherine Fisher, et al.. (2003). [3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter. Bioorganic & Medicinal Chemistry Letters. 13(7). 1291–1292. 23 indexed citations
10.
Petro, James B., et al.. (2002). Transitional Type 1 and 2 B Lymphocyte Subsets Are Differentially Responsive to Antigen Receptor Signaling. Journal of Biological Chemistry. 277(50). 48009–48019. 96 indexed citations
11.
Welch, Sandra P., John W. Huffman, & John Lowe. (1998). Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1301–1308. 104 indexed citations
12.
Rosen, Terry, Karen J. Coffman, Stafford McLean, et al.. (1998). Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(3). 281–284. 28 indexed citations
13.
Boyd, Owen, Thanos Paraschos, Susan Duffy, et al.. (1995). Follicular fluid levels of midazolam, fentanyl, and alfentanil during transvaginal oocyte retrieval*†. Fertility and Sterility. 64(5). 1003–1007. 49 indexed citations
14.
Wiley, Jenny L., et al.. (1995). Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34(6). 669–676. 97 indexed citations
15.
Gether, Ulrik, Teit E. Johansen, R. Michael Snider, et al.. (1993). Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor. Regulatory Peptides. 46(1-2). 49–58. 21 indexed citations
16.
Prabhakar, Nanduri R., R. Michael Snider, John Lowe, & Hailong Cao. (1993). Selective blockage of sensory response of the carotid body to hypoxia by NK-1 receptor antagonist CP-96,345. Regulatory Peptides. 46(1-2). 266–268. 2 indexed citations
17.
Nagahisa, Atsushi, Yoshihito Kanai, Osamu Suga, et al.. (1992). Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. European Journal of Pharmacology. 217(2-3). 191–195. 51 indexed citations
18.
Lowe, John, Thomas Seeger, A. Nagel, et al.. (1991). 1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. Journal of Medicinal Chemistry. 34(6). 1860–1866. 36 indexed citations
19.
Lowe, John. (1975). The Education of Adults: A World Perspective.. 29 indexed citations
20.
Lowe, John. (1956). Knowledge and communication. 24(1). 13–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026